Nature: March 27 2013
International calls for the pharmaceutical industry to share the results of clinical trials have grown ever more intense amid revelations that high-profile companies have hidden crucial data on safety and efficacy. Now Europe is moving towards measures that would significantly increase disclosure of such data.
The European Medicines Agency (EMA) in London, which licenses drugs for use in the European Union, is developing a policy to publish some clinical-trial data submitted by companies. And next month, major players in the UK medical community will meet to discuss the practical problems of data openness. Read more